Targeting success in heart failure Evidence-based management

被引：0
作者：
Gruszczynski, Adam B. [2 ]
Schuster, Brenda [3 ]
Regier, Loren [1 ]
Jensen, Brent [1 ]
机构：
[1] Saskatoon City Hosp, RxFiles Acad Detailing, Saskatoon Hlth Reg, Saskatoon, SK S7K 0M7, Canada
[2] Univ Saskatchewan, Dept Acad Family Med, Regina, SK, Canada
[3] Regina Qu Appelle Hlth Reg Saskatchewan, Saskatoon, SK, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2010年 / 56卷 / 12期
关键词：
CONSENSUS CONFERENCE RECOMMENDATIONS; VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; MORTALITY; COMBINATION; CANDESARTAN; MORBIDITY; OUTCOMES;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1313 / 1317
页数：5
相关论文
共 50 条
  • [31] Need for Increased Awareness and Evidence-Based Therapies for Patients Hospitalized for Heart Failure
    Butler, Javed
    Fonarow, Gregg C.
    Gheorghiade, Mihai
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (19): : 2035 - 2036
  • [32] Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes
    Gislason, Gunnar H.
    Rasmussen, Jeppe N.
    Abildstrom, Steen Z.
    Schramm, Tina Ken
    Hansen, Morten Lock
    Buch, Pernille
    Sorensen, Rikke
    Folke, Fredrik
    Gadsboll, Niels
    Rasmussen, Soren
    Kober, Lars
    Madsen, Mette
    Torp-Pedersen, Christian
    CIRCULATION, 2007, 116 (07) : 737 - 744
  • [33] Evidence-Based Heart Failure Performance Measures and Clinical Outcomes: A Systematic Review
    Maeda, Jared Lane K.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (05) : 411 - 418
  • [34] Potential impact of optimal implementation of evidence-based heart failure therapies on mortality
    Fonarow, Gregg C.
    Yancy, Clyde W.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Spertus, John A.
    Heidenreich, Paul A.
    AMERICAN HEART JOURNAL, 2011, 161 (06) : 1024 - U244
  • [35] Pharmacological management of chronic heart failure: old drugs, new drugs and new indications
    Lim, Wei Yao
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (02) : C18 - C22
  • [36] Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study
    Teng, Tiew-Hwa K.
    Tromp, Jasper
    Tay, Wan Ting
    Anand, Inder
    Ouwerkerk, Wouter
    Chopra, Vijay
    Wander, Gurpreet S.
    Yap, Jonathan J. L.
    MacDonald, Michael R.
    Xu, Chang Fen
    Chia, Yvonne M. F.
    Shimizu, Wataru
    Richards, A. Mark
    Voors, Adriaan
    Lam, Carolyn S. P.
    LANCET GLOBAL HEALTH, 2018, 6 (09): : E1008 - E1018
  • [37] Beyond Stage C: Considerations in the Management of Patients With Heart Failure Progression and Gaps in Evidence
    Carroll, Aubrie M.
    Farr, Maryjane
    Russell, Stuart D.
    Schlendorf, Kelly H.
    Truby, Lauren K.
    Gilotra, Nisha A.
    Vader, Justin M.
    Patel, Chetan B.
    Devore, Adam D.
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (05) : 818 - 831
  • [38] Management of Chronic Heart Failure in Adults: Synopsis of the National Institute for Health and Clinical Excellence Guideline
    Mant, Jonathan
    Al-Mohammad, Abdallah
    Swain, Sharon
    Laramee, Philippe
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (04) : 252 - +
  • [39] The Urgency of Doing Addressing Gaps in Use of Evidence-Based Medical Therapy for Heart Failure
    Greene, Stephen J.
    Felker, G. Michael
    JACC-HEART FAILURE, 2019, 7 (01) : 22 - 24
  • [40] Adherence to the evidence-based heart failure drug treatment: Are there sex-specific differences among new users?
    Kayibanda, J. F.
    Girouard, C.
    Gregoire, J. -P.
    Demers, E.
    Moisan, J.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (10) : 915 - 920
12345